Skip to main content

Table 3 Adverse events (AEs) considered related to study drug (reported in ≥2 patients)

From: Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study

Adverse event

AZD8848 (n = 26)

Placebo (n = 25)

Any drug-related AEs

22 (85)

11 (44)

Headache

4 (15)

0

Nasal dryness

2 (8)

1 (4)

Rhinorrhoea

0

2 (8)

Arthralgia

2 (8)

0

Pyrexia

2 (8)

0

  1. Data are presented as n (%)